Fosnetupitant (as chloride hydrochloride)/palonosetron (as hydrochloride): Solution concentrate for I.V. infusion containing fosnetupitant 235 mg and palonosetron 0.25 mg in 20 mL vial; Akynzeo®IV Page last updated: 30 June 2023 Public Summary Document (PSD) March 2023 PBAC Meeting - (PDF 1.2MB) Public Summary Document (PSD) March 2023 PBAC Meeting - (Word 660KB)